# CHLOROTHIAZIDE W/ RESERPINE
> **ANDA084853** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1983-07-06
## Drug
- **FDA Application Number:** ANDA084853
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHLOROTHIAZIDE W/ RESERPINE
- **Generic name:** Chlorothiazide
- **Active ingredients:** CHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WATSON LABS
- **First approval:** 1983-07-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084853)
---
*MORVS · CC0 1.0*